<DOC>
	<DOCNO>NCT02140918</DOCNO>
	<brief_summary>Fludrocortisone , association hydrocortisone , demonstrate improvement survival septic shock patient relative adrenal insufficiency . However , utility low dos steroid particular mineralocorticoid septic shock still discuss . The purpose investigator study investigate effect 3 increase dos fludrocortisone ( 100 μg , 200 μg , 400 μg ) order determine dose allow best pressor response phenylephrine healthy volunteer , simultaneously assess respective hemodynamic biological effect .</brief_summary>
	<brief_title>Fludrocortisone Healthy Volunteers ( AFLUCO4 )</brief_title>
	<detailed_description>In previous study ( AFLUCO2 ) healthy volunteer saline-induced hypoaldosteronism , investigator find single dos hydrocortisone fludrocortisone induced significant decrease pressor response phenylephrine , probably due rapid non-genomic vasodilatory mechanism , effect additive . The investigator also show , dos use septic shock , hydrocortisone induce pronounced mineralocorticoid effect fludrocortisone also induce systemic hemodynamic effect whereas fludrocortisone . The investigator want perform dose-response study normal condition ( ie without saline-induced hypoaldosteronism ) repeat administration , determine optimal dose fludrocortisone allow increase pressor response phenylephrine characterize concomitant hemodynamic biological effect . This placebo-controlled , randomize , double-blind , cross-over , 4-periods ( fludrocortisone 100 μg/day , 200 μg/day , 400 μg/day , placebo ) study aim investigate hemodynamic biological effect fludrocortisone administer orally 5 day , healthy volunteer . Each period separate next one washout interval least 14 day .</detailed_description>
	<mesh_term>Fludrocortisone</mesh_term>
	<criteria>Men age 20 25 year Body Mass Index 20 kg/m² 25 kg/m² Nonsmoker since least 6 month Normal clinical examination , electrocardiogram transthoracic echocardiography Normal routine biological parameter Written inform consent History significant allergy Resting heart rate &lt; 50 bpm Subjects abnormal hepatic renal function , cardiovascular , pulmonary , endocrine psychiatric disease Ongoing medication study Alcohol consumption 30g/day drug addiction Exclusion period mention national registry clinical trial volunteer . Subject legal protection</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Fludrocortisone</keyword>
	<keyword>Mineralocorticoids</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>